Dr. Liu's research program has been focused on investigating and developing novel molecular therapeutic strategies for human malignancies, delivered in conjunction with radiation therapy, along with investigating molecular aberrancies of several human malignancies including breast, and head/neck cancers. She has over 200 peer-reviewed publications on these topics, and has filed three patents. She currently holds peer-reviewed research funding from agencies including the Canadian Institutes of Health Research (CIHR) and the Canadian Cancer Society Research Institute (CCSRI). She is also the founding Director of a $1.9M Terry Fox Foundation Research Training Initiative, entitled “Strategic Training in Transdisciplinary Radiation Science for the 21st Century (STARS21)”, with the objective to train the next generation of trans-disciplinary scientists in Radiation Medicine. Recently, Dr. Liu's lab has shifted its focus to unraveling the mechanisms and identifying therapeutic strategies of radiation fibrosis and lymphedema, two important late normal tissue toxicities with significant functional morbidity.
Senior Scientist, Princess Margaret Cancer Centre
Staff Radiation Oncologist, Radiation Medicine Program, Princes Margaret Cancer Centre
Chief, Radiation Medicine Program, Princess Margaret Cancer Centre
Head, Department of Radiation Oncology, University Health Network
Professor, Departments of Radiation Oncology, Medical Biophysics, and Otolaryngology, University of Toronto
Chair, Radiation Oncology, University of Toronto